Vancouver, British Columbia--(Newsfile Corp. - June 30, 2014) - Roger Dumoulin-White, President & CEO of Theralase Technologies discusses this medical laser company with a therapeutic cold laser technology that is used to provide relief from pain, eliminate inflammation or to repair damaged tissues.
If you cannot view the video above, please visit:
http://www.ceoclips.com/companies/Video-Interview-with-Roger-Dumoulin-White-President-and-CEO-of-Theralase-Technologies.html
About Theralase Technology (TSXV: TLT)
Theralase Technologies Inc. designs, develops, manufactures and markets patented, superpulsed laser technology utilized in biostimulation and biodestruction applications. The technology is safe and effective in the treatment of chronic pain, neural muscular-skeletal conditions and wound care. When combined with its patented, light-sensitive Photo Dynamic Compounds, Theralase laser technology is able to specifically target and destroy cancers, bacteria and viruses. http://www.theralase.com
About CEO Clips:
CEO Clips is Canada's largest library of publicly traded company CEO videos. These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: BNN.ca, MSN Money, Thomson Reuters, Stockhouse.com, Canadian Business Journal, Germany's Investor SMS, and 32 sites in Europe. They are also disseminated via a video news release to several financial portals including TMX Money, Globe Investor, and The National Post.
BTV - Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com
